Partners
Auransa’s industry leading collaborations
Below are examples of how we partner with industry leaders to raise the standard of cancer care
Roche Genetech
We have partnered with Roche to investigate the use of our AI platform for discovering novel treatments for gastrointestinal (GI) toxicities. Similar to AU-018 for heart-safe chemotherapy, we aim to discover drug compounds that can protect patients from GI toxicity while undergoing cancer treatment.
POLARISqb
We have entered a research collaboration with Polaris qb (Quantum Biotech), combining our AI platform with their quantum computing capabilities, to discover novel treatments for diseases that disproportionately affect women, such as ovarian cancer and triple negative breast cancer.
USC Norris Cancer Center
The USC Norris Comprehensive Cancer Center is running the U.S. Phase 1 trial of AU-409 for advanced liver cancer and other solid tumors that metastasize to the liver. For more information or to see if you or a loved one is eligible to participate, please view the trial on ClinicalTrials.gov. Dr. Anthony El-Khoueirty is the lead physician for this trial.
Lee's Pharm
We are partnered with Lee’s Pharm, a major pharmaceutical company headquartered in China, to advance our clinical development of AU-018 for heart-safe chemotherapy, and AU-409 for advanced liver cancers, as part of clinical studies being conducted in China.
Auransa’s industry leading collaborations
Below are examples of how we partner with industry leaders to raise the standard of cancer care.
Roche Genetech
We have partnered with Roche to investigate the use of our AI platform for discovering novel treatments for gastrointestinal (GI) toxicities. Similar to AU-018 for heart-safe chemotherapy, we aim to discover drug compounds that can protect patients from GI toxicity while undergoing cancer treatment.
Lee's Pharm
We are partnered with Lee’s Pharm, a major pharmaceutical company headquartered in China, to advance our clinical development of AU-018 for heart-safe chemotherapy, and AU-409 for advanced liver cancers, as part of clinical studies being conducted in China.
USC Norris Cancer Center
The USC Norris Comprehensive Cancer Center is running the U.S. Phase 1 trial of AU-409 for advanced liver cancer and other solid tumors that metastasize to the liver. For more information or to see if you or a loved one is eligible to participate, please view the trial on ClinicalGovs.org. Dr. Anthony El-Khoueirty is the lead physician for this trial.
POLARISqb
We have entered a research collaboration with Polaris qb (Quantum Biotech), combining our AI platform with their quantum computing capabilities, to discover novel treatments for diseases that disproportionately affect women, such as ovarian cancer and triple negative breast cancer.
